P1429: IN VITRO COMPARISON OF THE EFFECTS OF INCLACUMAB VS CRIZANLIZUMAB ON REDUCING ENDOTHELIAL ADHESION OF RED BLOOD CELLS IN STANDARDIZED MICROFLUIDIC PLATFORM

相似书籍

• P1439: EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS
  由: Moayed Hamza, et al.
  出版: (2023-08-01)
• P-030: CRIZANLIZUMAB REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SCD PATIENTS IN STANDARDIZED MICROFLUIDIC PLATFORM: IN VITRO TECHNOLOGY ASSESSMENT
  由: FEDERICI C., et al.
  出版: (2022-08-01)
• Potential mechanism of circKIAA1429 accelerating the progression of hepatocellular carcinoma
  由: Yiting Yuan, et al.
  出版: (2025-03-01)
• S107: P-SELECTIN INHIBITOR INCLACUMAB REDUCES CELL ADHESION IN AN IN-VITRO ASSAYS SHOWING POTENTIAL FOR PREVENTION OF VASO-OCCLUSION EVENTS IN SICKLE CELL DISEASE
  由: M Tarasev, et al.
  出版: (2022-01-01)
• Crizanlizumab in adult patients with sickle cell disease: a retrospective German analysis
  由: Friederike Poppenborg, et al.
  出版: (2024-05-01)